Pharmacological groups:
Species:
Manufacturer:
Form of the drug:
Detailed description
Composition
The vaccine contains attenuated strains of canine distemper virus, canine adenovirus-2, canine parvovirus, canine parainfluenza virus, as well as inactivated strains of leptospira serogroups Canicola, Icterohaemorrhagia, Pomona, Grippotyphosa.
Properties
14 days after the application of the vaccine according to the recommended scheme, active immunity is formed, which lasts up to 1 year against canine distemper (CDV) caused by canine distemper virus, infectious hepatitis caused by adenovirus type 1 (CAV-1), respiratory diseases caused by adenovirus type 2 (CAV-2), parainfluenza (CPiV) caused by canine parainfluenza virus, parvovirus (CPV) and leptospirosis caused by Leptospira canicola, Leptospira grippotyphosa, Leptospira icterohaemorrhagiae, Leptospira pomona
Doses and method of application
Aseptically dissolve the lyophilized vaccine component with the liquid fraction (sterile suspension), shake well and inject 1 ml subcutaneously or intramuscularly.
Primary Vaccination: In clinically healthy dogs, administer 2 doses 3 weeks apart. Primary vaccination puppies under 9 weeks of age should be given 3 doses of the combination vaccine at 3 week intervals to prevent interaction with maternal antibodies.
Revaccination: Annual revaccination with one dose is recommended.
Storage conditions
Dry, dark, out of the reach of children at a temperature of +2°C to +7°C. Do not freeze!
Best before date
18 months. The contents of the vial must be used immediately after opening.
